MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Imago BioSciences, Inc. - Common stock (NQ:IMGO)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Imago BioSciences, Inc. - Common stock

< Previous 1 2 3 Next >
News headline image
7 Healthcare Stocks That Will Be Big Winners in 2023 ↗
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider. 
Via InvestorPlace
News headline image
5 Top Pharma Stocks of 2022 to Buy for the Long Haul ↗
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks. 
Via InvestorPlace
News headline image
Looking Into Imago BioSciences's Recent Short Interest ↗
Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently reported that it has 1.00 million shares sold short, which is 3.97% of all regular... 
Via Benzinga
News headline image
5 Most Expensive Health Care Stocks You Should Worry About ↗
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
From Merck & Co., Inc.
Via Business Wire
News headline image
Analyst Ratings for Imago BioSciences ↗
 
Via Benzinga
What 5 Analyst Ratings Have To Say About Imago BioSciences ↗
 
Via Benzinga
News headline image
Expert Ratings for Imago BioSciences ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Imago BioSciences? ↗
Imago BioSciences's (NASDAQ:IMGO) short percent of float has fallen 3.48% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 13.61% of all regular... 
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
3 Dow Stocks to Take Seriously in 2023 ↗
The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022 ↗
 
Via Benzinga
News headline image
IMAGO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Imago BioSciences, Inc. - IMGO
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday ↗
 
Via Benzinga
TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune
Via AB Newswire
Topics Death Economy Stocks
News headline image
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash. 
Via Benzinga
News headline image
Nasdaq Down More Than 100 Points; Gold Falls 1% ↗
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Monday. 
Via Benzinga
News headline image
Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  During Monday's session, 50 stocks hit new 52-week highs. 
Via Benzinga
News headline image
OPEC Rumors, Energy Stocks Drag Wall Street ↗
The Dow Jones Industrial Average and Nasdaq Composite are both down over 90 points midday, while the S&P 500 Index sits comfortably below fair value as well. 
Via Talk Markets
News headline image
Crude Oil Down Over 5%; Imago BioSciences Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Monday. 
Via Benzinga
News headline image
Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 70 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Imago BioSciences (NASDAQ: IMGO) to be Acquired by Merck (NYSE: MRK) for $1.35 Billion
Imago BioSciences, Inc. (NASDAQ: IMGO) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development 
Via Spotlight Growth
News headline image
As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled ↗
Markets sent mixed messages to start out Thanksgiving week. 
Via The Motley Fool
News headline image
Why Is Imago Biosciences (IMGO) Stock Up 105% Today? ↗
Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share. 
Via InvestorPlace
News headline image
Nasdaq Drops Over 50 Points; Bob Iger Returns To Walt Disney ↗
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Monday. 
Via Benzinga
News headline image
Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout ↗
Seagen who? Merck is putting its cash to work buying a smaller biotech company. 
Via Investor's Business Daily
News headline image
IMGO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Imago BioSciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Cancer-Focused Imago BioSciences Shares Soar After Merck Deal ↗
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story